[Pubmed] Epigenome-wide DNA methylation analysis of myasthenia gravis
Posté : 31 mai 2023 12:00
FEBS Open Bio. 2023 May 31. doi: 10.1002/2211-5463.13656. Online ahead of print.
ABSTRACT
Myasthenia gravis (MG) is a common neuromuscular junction (NMJ) disorder and autoimmune disease mediated by several antibodies. Several studies have shown that genetic factors play an important role in MG pathogenesis. To gain insight into the epigenetic factors affecting MG, we report here genome-scale DNA methylation profiles of MG. DNA was extracted from 8 MG patients and 4 healthy controls for genome-wide DNA methylation analysis using the Illumina HumanMethylation 850K BeadChip. Verification of pyrosequencing was conducted based on differential methylation positions (DMPs). Subsequently, C2C12 and HT22 cell lines (derived from mouse) were treated with demethylation drugs. Transcribed mRNA of the screened differential genes were detected using quantitative Real-time PCR. The control and MG group were compared, and two key probe positions were selected. The corresponding genes were CAMK1D and CREB5 (P
Source: https://pubmed.ncbi.nlm.nih.gov/3725465 ... t6+86293ac